NDC 0004-0402
Mircera
Methoxy Polyethylene Glycol-epoetin Beta
Mircera is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Genentech, Inc.. The primary component is Methoxy Polyethylene Glycol-epoetin Beta.
| Product ID | 0004-0402_2f92af4c-a3cd-46f7-a171-2a90170955b4 |
| NDC | 0004-0402 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Mircera |
| Generic Name | Methoxy Polyethylene Glycol-epoetin Beta |
| Dosage Form | Injection, Solution |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2014-10-24 |
| Marketing End Date | 2019-07-31 |
| Marketing Category | BLA / BLA |
| Application Number | BLA125164 |
| Labeler Name | Genentech, Inc. |
| Substance Name | METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA |
| Active Ingredient Strength | 75 ug/.3mL |
| Pharm Classes | Erythropoiesis-stimulating Agent [EPC],Erythropoietin [CS],Increased Erythroid Cell Production [PE] |
| NDC Exclude Flag | N |
Packaging
NDC 0004-0402-09
1 SYRINGE, GLASS in 1 CARTON (0004-0402-09) > 1 mL in 1 SYRINGE, GLASS
| Marketing Start Date | 2014-10-24 |
| NDC Exclude Flag | N |
| Sample Package? | N |
NDC SPL Data Element Entries
NDC 0004-0402-09 [00004040209]
Mircera INJECTION, SOLUTION
| Marketing Category | BLA |
| Application Number | BLA125164 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2014-10-24 |
| Marketing End Date | 2019-07-31 |
Drug Details
Active Ingredients
| Ingredient | Strength |
|---|---|
| METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA | 75 ug/.3mL |
Pharmacological Class
- Erythropoiesis-stimulating Agent [EPC]
- Erythropoietin [CS]
- Increased Erythroid Cell Production [PE]
NDC Crossover Matching brand name "Mircera" or generic name "Methoxy Polyethylene Glycol-epoetin Beta"
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0004-0401 | Mircera | Methoxy polyethylene glycol-epoetin beta |
| 0004-0402 | Mircera | Methoxy polyethylene glycol-epoetin beta |
| 0004-0403 | Mircera | Methoxy polyethylene glycol-epoetin beta |
| 0004-0404 | Mircera | Methoxy polyethylene glycol-epoetin beta |
| 0004-0406 | Mircera | Methoxy polyethylene glycol-epoetin beta |
| 59353-400 | Mircera | Methoxy polyethylene glycol-epoetin beta |
| 59353-401 | Mircera | Methoxy polyethylene glycol-epoetin beta |
| 59353-402 | Mircera | Methoxy polyethylene glycol-epoetin beta |
| 59353-403 | Mircera | Methoxy polyethylene glycol-epoetin beta |
| 59353-404 | Mircera | Methoxy polyethylene glycol-epoetin beta |
| 59353-405 | Mircera | Methoxy polyethylene glycol-epoetin beta |
| 59353-406 | Mircera | Methoxy polyethylene glycol-epoetin beta |
| 59353-407 | Mircera | Methoxy polyethylene glycol-epoetin beta |
| 59353-408 | Mircera | Methoxy polyethylene glycol-epoetin beta |
Trademark Results [Mircera]
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 MIRCERA 88820445 not registered Live/Pending |
Genentech, Inc. 2020-03-04 |
 MIRCERA 87146117 not registered Live/Pending |
HOFFMANN-LA ROCHE INC. 2016-08-22 |
 MIRCERA 85888871 not registered Dead/Abandoned |
HOFFMANN-LA ROCHE INC. 2013-03-28 |
 MIRCERA 78304603 3237894 Dead/Cancelled |
Hoffmann-La Roche Inc. 2003-09-24 |
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.